Reduction of Immunosuppression as Initial Therapy for Post-Transplantation Lymphoproliferative Disorder

Reduction of immunosuppression (RI) is commonly used to treat post-transplant lymphoproliferative disorder (PTLD) in solid organ transplant recipients. We investigated the efficacy, safety and predictors of response to RI in adult patients with PTLD. 67 patients were managed with RI alone and 30 pat...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Reshef, R, Vardhanabhuti, S, Luskin, MR, Heitjan, DF, Hadjiliadis, D, Goral, S, Krok, KL, Goldberg, LR, Porter, DL, Stadtmauer, EA, Tsai, DE
Формат: Artigo
Язык:Inglês
Опубликовано: 2011
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3079420/
https://ncbi.nlm.nih.gov/pubmed/21219573
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1600-6143.2010.03387.x
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы